Hearing loss

Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)

Retrieved on: 
Monday, December 18, 2023

The trial assesses several outcome measures, including the rate and severity of ototoxicity, the change from baseline in Pure Tone Audiometry (PTA) (dB) throughout the study and the tolerance.

Key Points: 
  • The trial assesses several outcome measures, including the rate and severity of ototoxicity, the change from baseline in Pure Tone Audiometry (PTA) (dB) throughout the study and the tolerance.
  • Géraldine Honnet, Chief Medical Officer of Sensorion, said: “I’m pleased with the progress in Sensorion’s POC Phase 2a clinical study of SENS-401 in the prevention of Cisplatin-Induced Ototoxicity.
  • SENS-401 is also progressing in a second ongoing Phase 2a clinical study in the prevention of residual hearing loss following cochlear implantation.
  • Sensorion is anticipating the end of patient recruitment early 2024 and the publication of POC Phase 2a clinical primary endpoint readout in H1 2024.

US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer

Retrieved on: 
Thursday, December 14, 2023

High-risk neuroblastoma is a challenging disease, with a high mortality rate driven primarily by the risk of relapse after achieving remission.

Key Points: 
  • High-risk neuroblastoma is a challenging disease, with a high mortality rate driven primarily by the risk of relapse after achieving remission.
  • US WorldMeds partnered with the Beat Childhood Cancer Research Consortium at Penn State University, which conducted the preclinical and clinical research to help advance this vital therapy.
  • The Consortium represents a group of over 50 hospitals that offer collaboration through a network of childhood cancer clinical trials.
  • “We are thankful for the dedication of our partners, specifically the Beat Childhood Cancer Research Consortium, who work tirelessly to improve treatment outcomes for pediatric cancer patients.

AudioCure Pharma Receives Hearing Technology Innovator Award for its Innovative Compound AC102 for the Treatment of Sudden Hearing Loss

Retrieved on: 
Thursday, December 7, 2023

AudioCure Pharma GmbH announced today that it has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards™, honoring technological innovation and breakthroughs in the hearing industry.

Key Points: 
  • AudioCure Pharma GmbH announced today that it has been awarded for its innovative compound AC102 by the Hearing Technology Innovator Awards™, honoring technological innovation and breakthroughs in the hearing industry.
  • View the full release here: https://www.businesswire.com/news/home/20231205308215/en/
    Dr. Reimar Schlingensiepen (left, CEO of AudioCure Pharma GmbH) and Prof. Hans Rommelspacher (founder and CSO) receive the award in the therapeutics category.
  • (Photo: AudioCure Pharma)
    AudioCure is developing the therapeutic small molecule AC102 to treat hearing impairments including Sudden Sensorineural Hearing Loss (SSNHL).
  • Reimar Schlingensiepen, CEO of AudioCure, said: “Receiving the Hearing Technology Innovator Award underscores the urgent need for advanced solutions in treating conditions like SSNHL.

Advanced Bionics Extends Marvel CI Product Offering With Remote Programming and Expanded Linked Two-ear Solutions

Retrieved on: 
Monday, December 4, 2023

Remote Programming is another step towards improving accessibility for hearing healthcare for as many people as possible.

Key Points: 
  • Remote Programming is another step towards improving accessibility for hearing healthcare for as many people as possible.
  • Now AB’s Marvel will also be the only CI system with a CROS (Contralateral Routing of Signal) device.
  • Together with a pair of Marvel CI sound processors, or a bimodal pairing with Marvel CI and a Phonak Link M hearing aid, the introduction of CROS makes Marvel the only CI system with linked bilateral, bimodal, and CROS configurations.
  • “Since its introduction in 2020, Marvel CI has redefined hearing performance with cochlear implants," said Victoria E.Carr-Brendel, Ph.D., GVP, Sonova Group and President of Advanced Bionics.

Amplifon, Hearing Care Experts, Expands Its Footprint in Alberta and Reaches More Than 130 Stores in Canada

Retrieved on: 
Wednesday, November 29, 2023

Amplifon, world leader in hearing care services and solutions, has surpassed 130 stores across Canada as it strengthens its presence in Alberta through the acquisition, earlier this year, of Living Sounds Hearing Centre, with 20 clinics in the province – operating mostly in the Edmonton area.

Key Points: 
  • Amplifon, world leader in hearing care services and solutions, has surpassed 130 stores across Canada as it strengthens its presence in Alberta through the acquisition, earlier this year, of Living Sounds Hearing Centre, with 20 clinics in the province – operating mostly in the Edmonton area.
  • Amplifon, with its mission to empower people to rediscover all the emotions of sound, will now bring its global excellence, combined with the local expertise of its hearing care professionals, to communities in and around Alberta.
  • “We are thrilled to join hands with the Living Sounds’ clinics and professionals to support this community with their hearing loss needs,” said Diego Alejandre, General Manager for Amplifon Canada.
  • “Historically, there has been a stigma surrounding hearing difficulties, and some people found it hard to open up about their challenges.

For Acclaimed Baroque Flutist Stephen Schultz, Classic Rock Prompted a Journey to Better Hearing -- and Widex MOMENT Sheer Hearing Aids

Retrieved on: 
Thursday, December 14, 2023

Decades into a celebrated career as a musician and educator, renowned Baroque flutist Stephen Schultz needed hearing aids.

Key Points: 
  • Decades into a celebrated career as a musician and educator, renowned Baroque flutist Stephen Schultz needed hearing aids.
  • Facing a choice between hearing aids and an operation that might fix the tiny bones in his ears, Schultz waited.
  • And that's the journey that led Schultz to the Widex Moment Sheer hearing aids he wears today.
  • "Yes, hearing aids amplify sound, but really good ones like my Widex Moment Sheer hearing aids let you hear the rich palate that you'd normally miss," he says.

Sorenson Launches Sound Off Project to Support Veterans with Hearing Loss

Retrieved on: 
Tuesday, December 12, 2023

Sorenson provides innovative and easy-to-use communication solutions to those with eligible hearing loss who need captions to use a phone.

Key Points: 
  • Sorenson provides innovative and easy-to-use communication solutions to those with eligible hearing loss who need captions to use a phone.
  • We are dedicated to empowering military service members and veterans who live with hearing loss," said Jorge Rodriguez, CEO of Sorenson, which connects more than 140 million conversations across all business lines annually.
  • "This initiative is a call to action, a pledge from Sorenson to advocate for veterans; and, a commitment to support our Veteran communities."
  • "The Sound Off Project is a much-needed initiative to help to raise awareness about hearing loss and provide my fellow veterans with the support and resources they need.

Oberkotter Foundation Announces Dr. Teresa Caraway as CEO

Retrieved on: 
Friday, December 8, 2023

Dr. Caraway succeeds Bruce Rosenfield, trustee, who has served as the executive director of the Foundation for over 20 years.

Key Points: 
  • Dr. Caraway succeeds Bruce Rosenfield, trustee, who has served as the executive director of the Foundation for over 20 years.
  • She first joined the organization in 2012 as the CEO of Hearing First, an educational initiative of the Oberkotter Foundation that supports families and professionals on the LSL journey through awareness, education, and community.
  • "I am humbled and excited to take on the role of CEO at the Oberkotter Foundation.
  • "Dr. Caraway's visionary leadership makes her the ideal leader to guide the Oberkotter Foundation through its next phase of growth and impact.

Hearing First Unveils 2024 Course Catalog with New Pediatric Audiology Offerings

Retrieved on: 
Thursday, December 7, 2023

PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Hearing First, a subsidiary of the Oberkotter Foundation, has announced its 2024 course catalog. The catalog features new and return courses focused on pediatric audiology and Listening and Spoken Language (LSL) best practices to improve LSL outcomes for children who are deaf or hard of hearing. All courses are free to attend and learners can earn CE credits from the American Academy of Audiology (AAA), AG Bell Academy, and American Speech Language and Hearing Association (ASHA). The 2024 course catalog opened for registration earlier this week.

Key Points: 
  • PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Hearing First , a subsidiary of the Oberkotter Foundation , has announced its 2024 course catalog.
  • The catalog features new and return courses focused on pediatric audiology and Listening and Spoken Language (LSL) best practices to improve LSL outcomes for children who are deaf or hard of hearing.
  • Hearing First courses translate the latest research and evidence-based science for hearing healthcare industry professionals to apply to their practice.
  • In 2024, Hearing First expanded its course offerings and increased the number of pediatric-audiology focused courses to help achieve that goal."

GN and Soundly Presents "Inside the Ear", Digital Art Campaign Aiming to Transform Hearing Health Awareness

Retrieved on: 
Thursday, November 30, 2023

BALLERUP, Denmark, Nov. 30, 2023 /PRNewswire/ -- GN, the global leader in hearing aid innovation, and Soundly, a consumer education resource for hearing wellness, have joined forces once again to present "Inside the Ear," a digital art campaign aimed at demystifying hearing loss and hearing health. The campaign, launching today, showcases a series of fascinating and educational videos created by award-winning digital artist, Design Cells, which beautifully illustrate the complex inner workings of the ear.

Key Points: 
  • The campaign explores the inner workings of the ear through vibrant visuals, empowering consumers with a deeper understanding of their hearing health.
  • BALLERUP, Denmark, Nov. 30, 2023 /PRNewswire/ -- GN, the global leader in hearing aid innovation, and Soundly, a consumer education resource for hearing wellness, have joined forces once again to present "Inside the Ear," a digital art campaign aimed at demystifying hearing loss and hearing health.
  • GN and Soundly unite with a shared vision to cultivate greater awareness and education surrounding the crucial significance of maintaining optimal hearing health.
  • Explore the complete "Inside the Ear" digital art collection and delve into the significance of hearing health by clicking here .